Insider · CIK 0001382281
Chan Galbato
Files at EML (EASTERN CO), ARAY (ACCURAY INC). First filing Dec 17, 2025, latest Sep 17, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EML: EASTERN CO
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | EASTERN CO | $31k 1,217 shares | +29% | - | |
| 45Moderate | EASTERN CO | $20k 962 shares | +42% | +16% from low-22% from high | |
| 58Moderate | EASTERN CO | $20k 1,029 shares | +83% | +6% from low-34% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | EML EASTERN CO | POpen-market purchase Common Shares | +1,217 | $25.25 | $31k | 5,384 | 25 d ago |
| Mar 16, 2026 | EML EASTERN CO | POpen-market purchase Common Shares | +962 | $20.93 | $20k | 3,227 | Mar 17, 2026 |
| Dec 16, 2025 | EML EASTERN CO | POpen-market purchase Common Shares | +1,029 | $19.55 | $20k | 2,265 | Dec 17, 2025 |
| Nov 28, 2025 | ARAY ACCURAY INC | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 50,000 | Dec 2, 2025 |
| Nov 28, 2025 | ARAY ACCURAY INC | AGrant or award Restricted Stock Unitsderivative | +56,603 | $0.00 | $0 | 56,603 | Dec 2, 2025 |
| Sep 17, 2025 | EML EASTERN CO | AGrant or award Common Shares | +806 | $24.98 | $20k | 1,236 | Oct 1, 2025 |
| Jun 17, 2025 | EML EASTERN CO | AGrant or award Common Shares | +430 | $23.36 | $10k | 430 | Jun 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.